ReviewCurrent neuropharmacology2024

Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.

Daniel J van Wamelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.